Regulation of medical devices has been one of the most prominent initiatives of the European Union in the health domain. The recent Medical Device Regulation 2017/745/EEC extended the definition of medical devices to standalone software systems with prognostic and prevision intended purposes. This paradigm shift stimulates the development of more lightweight software systems such as mobile applications, that can be classified as legitimate medical devices and can be prescribed to patients. This new context creates the need for an urgent adjustment of the currently used software development life cycle models and processes. This article discusses a tailored agile approach based on the Scrum model, designed to be compliant with the international standards for medical device software development and benefit the creation of software solutions according to the current Medical Device Framework. The discussion in this paper demonstrates there is no reason to believe that agile methodologies should not benefit the process of creating software solutions in the medical device domain.
INTRODUCTION
The strong presence of software systems in the medical industry is undeniable. In fact, over 50% of all medical devices directly depend on software in some way (Allen, 2014) . This dependency exists because software solutions show great potential to provide a positive change for patients, their families and even healthcare professionals. Proof of this growth is the fact that the medical technology ecosystem registered more that one hundred thousand patents in the year of 2012, turning out to be the most innovative industry in the world (Gloger, 2013) .
On the other hand, this industry presents unique challenges for software system development. The current state of software systems in healthcare is considered to be relatively primitive (Goldsmith, 2006; Kruger and Kruger, 2012 ) when compared to the financial or retail industries. This is a direct result of the level of complexity and demanding nature of medical services.
It is impossible to create a standardized inventory for healthcare services, rather, they must be customized at point of care, as soon as possible and according to specific circumstances. There is also tremendous variation in physician response to diagnostic uncertainty from case to case, meaning that there is great potential for collision between stakeholders at the point of service.
Furthermore, the medical industry as a whole is characterized by a strong influence of regulatory entities concerning the development of medical devices and information technology systems. Technological endeavors must submit to a strict certification process and compliance testing to a pre-established set of standards and requirements. Compliance authorities are motivated by the need to avoid additional risk for patients and healthcare professionals. As such, to survive the certification processes and obtain approval, it is certainly necessary to have high quality standards, namely in the engineering life cycle itself.
It is paramount to reinforce that regulatory supervision does not concern itself only with the product's performance, but also with the way it's developed. There is a strong conviction that a rigorous, systematic engineering process leads to trustworthy devices.
The idea that the products we buy and use in our day-to-day lives should be regulated in order to ensure that they are safe and fit for its claimed purpose is something that most individuals assumes is true. When we purchase furniture or articles of clothing, it's safe to say that we take for granted that they meet a set of requirements guaranteeing the safety of its use. With the devices involved in healthcare (including software products), the need for safety is particularly important. From a patient's perspective, there is an assumption that all systems meet a thorough set of quality standards; and from the perspective of the healthcare professionals, it's imperative that quality is assured, in order to avoid unwanted incidents that could put their professional duties at stake (Quinn, 2017) . This paper will focus on the software engineering development life cycle and processes that aim to make the development of medical device software systems more agile and at the same time guarantee their quality.
Chapter 2 will look at the entire ecosystem of legal restrictions and international standards that are responsible for regulating medical device development in the European Union. This chapter aims to give a broad insight to what are the demands and requirements software teams have to comply in order to provide all the quality evidences needed to introduce certified medical devices in productive environments. Also, it will discuss an exciting change in the European framework that will have a great impact on the medical device software landscape.
In chapter 3, we will discuss software development life cycle methodologies. A comparison will be made between plan driven and agile approaches, detailing each one's main advantages and pitfalls concerning development for medical device software following the aforementioned requirements and standards.
As for chapter 4, it will present a novel tailored agile process life cycle model specifically designed to be compliant with the main standards concerning development for medical devices.
Most definitions of critical systems base themselves on the degree of consequences that result from a failure (Knight, 2002) . According to this standard, it's intuitive to state that the systems developed for the medical industry can be classified as critical.
MEDICAL DEVICE DEVELOPMENT IN THE EU
Until the late nineties, each member state of the European Union would implement its own approach to regulate medical devices. However, to promote EU's internal market circulation, as well as to regulate an increasingly complex market, the European Council introduced new regulations that became known as the "new approach directives". These would enforce a set of essential requirements to assure safety and performance among medical devices (Sorenson and Drummond, 2014) . The directives apply to all member states, meaning that if a medical device receives EU's seal of approval, it's certified for all countries. ( /47/EC, 2007 . This framework aimed to unify the basic requirements for safety regarding medical devices, as well as to specify procedures regarding documentation and audit processes which manufacturers need to comply with in order to produce and sell medical devices. It is mandatory to comply with these procedures to gain the European Council certification, as stated in Article 4 of directive 93/42/EEC.
The Medical Device Framework
Medical device approval inside the EU is supervised by what is called a competent authority, such as the Medicine and Healthcare Products Regulatory Agency in the UK and INFARMED in Portugal (Kramer et al., 2012) . Low risk devices are declared directly to the competent authorities, that can initiate inspections and confirm production and development standards, as well as perform reviews on technical documentation. As for more complex devices, approval is the responsibility of independent corporations specialized in the matter, designated by the competent authorities (Quinn, 2017; Kramer et al., 2012) .
The risk associated with the use of the medical device is the determining factor for its classification. The needed evidences and requirements to gain regulatory approval are dependent on this risk classification. Low risk devices are classified as Class I, medium risk as Class II and high risk as Class III.
The decision to be compliant with the set of requirements stated in the MDF represent a clear commitment for medical device manufacturers, as it demands a significant amount of financial and time resources. This can be a worthy investment because the certification allows access to a huge market. However, because the process of acquiring the certification is such a burden, the MDF includes the important concept of intended purpose into the definition of what actually constitutes a medical device. What this means is that without the explicit intention of a manufacturer to create a medical device, there is not one, even if the device seemingly meets every other criteria.
International Standards
In case a device manufacturer takes on the commitment of being certified according to the European requirements, it must behave according to a set of international standards that supply the needed guidelines to achieve it. In the healthcare domain, the ISO 13485:2016 (ISO 13485:2016 (ISO 13485: , 2016 ) standard stipulates the necessary requirements concerning quality management systems (QMS). This standard is based on the ISO 9001:2015 (ISO 9001:2015 (ISO 9001: , 2015 and can be considered an extension of the same. Corporations should use these standards to make a self-evaluation about their ability to respond effectively to their customers' needs.
ISO 13485:2016 does not, however, supply guidelines specifically for software development. The IEC 62304:2006 standard (IEC 62304 :2006 (IEC 62304 : , 2006 fills this flaw, offering the necessary recommendations concerning software development life cycles, security and maintenance of software systems for medical devices. This standard has an underlying assumption that the corporation develops according to a quality management system, but does not demand certification by the ISO 13485:2016 standard. As such, IEC 62304:2006 can be regarded as a supplement to ISO 13485:2016, specific for software development.
The IEC 62304:2006 standard bases itself on ISO/IEC 12207:1995 (ISO/IEC 12207:1995 , 1995 , that while being a comprehensive standard about software development life cycles and processes, has already been deprecated, firstly when it was replaced by ISO/IEC 12207:2008 and secondly when it was upgraded into ISO/IEC 12207:2017, the most recent version. However, the same standard is still considered critical for medical device software developers as it's the only standard that supplies specific guidelines for this purpose. Additionally, the norm includes a safety classification that complements MDF's classification. The classes shall be assigned according to the possible effects on the patient, operator, or other people resulting from a hazard to which the system can contribute:
1. Class A applies in case no injury or damage is possible; 2. Class B applies in case a non-serious injury is possible;
3. Class C applies in case death or a serious injury is possible;
There is an obvious relationship between this classification and the one provided by the MDF. Nonetheless, the connection between the two is not straightforward, because meanwhile MDF's classification applies to the device as a whole, IEC 62304:2006's classification only applies to software components, which may or may not represent all the components of the medical device, in fact, the device may include several software components, each one with a different safety classification. On the other hand, if a given software component is responsible for a critical functionality, this link is direct, simply because a failure in this component will result in a failure of the device. Generally, it's safe to state that the software's safety classification will never be higher that the classification of the device (Pikkarainen, 2016) .
The IEC 62304:2006 also provides important guidelines concerning the software development life cycle, namely important activities that the development model shall include.
1. The development process is of particular interest concerning this paper. The standard demands the creation of a development planning document, where the manufacturer shall state all the activities involved in the engineering process, as well as the system's safety classification.
2. The maintenance process, where the manufacturer must state what are the concrete actions that are consequence of customer feedback.
3. The risk management process. The manufacturer shall document a process for risk management and include it in the development plan. For such, the 14971:2007 shall be used.
4. The configuration management process, must also be included in the development plan and includes a list of all items that must be controlled, traced and versioned.
5. The problem resolution process. The standard dictates that the manufacturer must provide a report for each identified problem, as well as detail strategies for investigating and resolving the problem.
Even with this set of recommendations, it's important to reinforce all the liberties given by the standard. It does not make restrictions concerning the contents of the produced documentation and, most importantly, it does not enforce a development life cycle model.
The Medical Device Regulation
The IEC 62304:2006 makes the assumption that all software components are part of an embedded medical device and, as a result, it does not include all the system requirements for software. The standard that aims to achieve this is IEC 60601-1 (IEC 60601-1-11:2015 (IEC 60601-1-11: , 2015 , concerning electrical equipment, however, in 2007, when MDF's directives where amended, standalone software systems where included in the definition of medical device, meaning that software products could be officially classified as medical devices.
This amendment unveiled a gap in the international standards to date, because of the fact that there was no publication with guidelines concerning standalone behavior of software as legitimate a medical device (McHugh et al., 2011) . The 2007/47/EC directive includes software in its definition of medical device and goes beyond that, reinforcing this idea in Recital 6:
It is necessary to clarify that software in its own right, when specifically intended by the manufacturer to be used for one or more of the medical purposes set out in the definition of a medical device, is a medical device. Software for general purposes when used in a healthcare setting is not a medical device.
The profound changes introduced by this amendment gave wings to the possibility of creation of standalone software certified as a medical device, which is the case of FibriCheck, a smartphone application for the monitoring of arrhythmias(FibriCheck, ).
As of April 2017, the Regulation for Medical Devices 2017/45/EC (RDM) (2017 ( /745/EEC, 2017 was adopted by the European Union, and replaced MDF's directives 90/385/EEC and 93/42/EEC, as well as its amendments. Unlike directives, regulations are directly applicable to all member states without the need of an individual implementation in each member state's local law.
This regulations introduces significant changes to its predecessors in some aspects.
Firstly, the definition of medical device was expanded for equipments that aim to perform diagnostic or prediction of diseases.
As such, a software application capable of measuring the risk for contracting some disease based on data collected through sensors could be certified as a medical device, if the manufacturer declares this as an intended purpose.
The regulation states exceptions for devices whose intended purposes are related to non-clinical duties such as lifestyle and well-being, but manufacturers have to provide proper justification, as to avoid arbitrary classifications to avoid the burden of certification.
This expansion of the definition of medical device, put together with new safety classification rules specifically for software has exciting implications for the software development industry. According to the new regulations many applications that did not fit the definition of medical device now do, probably with a classification of Class II. Any software enthusiast can imagine the implications for corporations that work with technologies such as big data and analytics, experts in the field of prognostic and prediction (Lee and Yoon, 2017) .
SOFTWARE LIFE CYCLES FOR MEDICAL DEVICE DEVELOPMENT
Software engineering is a big part of what makes software products reliable and valuable. As stated by the IEEE, it consists of the application of a systematic, disciplined, quantifiable approach to the development, operation and maintenance of software (IEEE, 1993) . Additionally, software engineering processes define the needed structure to deliver technology solutions efficiently (Ian Sommerville, 2010) . They provide a basis for project control and management, context from which methods and techniques are applied, milestones are defined and quality is assured. At this stage, it's extremely important to state that a software engineering process does not aim to be a rigid prescription of how to build software products, rather, it should be faced as an adaptable approach for teams to pick the most appropriate set of tasks and actions according to the available resources. The ultimate goal should always be to deliver high quality products in the established time frame and obtain customer satisfaction.
Even though that's true, life cycle models for software development provide an important script for the success of any project (Pressman, 2009) and the choice of which one to follow is always an interesting argument to have. Some would argue that the only irresponsible strategy would be to try to standardize and impose the same development model for every situation (Vogel, 2011) , but the benefits of following a model are consensual. Without following defined steps during development, it becomes extremely hard Towards an Agile Development Model for Certifiable Medical Device Software -Taking Advantage of the Medical Device Regulation to keep track of the project's state, manage milestones and assign tasks to team members. This control allows an increase of productivity and overall quality, but more importantly in the domain of critical systems, it allows to create quality evidences for regulatory entities.
The intangible nature of software allows for a great variety concerning life cycle models, that can differ in aspects such as overall flow, work products, level of discipline, customer involvement and team autonomy.
Plan Driven Approaches
Considered the first approach to software development, the waterfall model, credited to Winston W. Royce (Royce, 1970) , is a popular example of a plandriven approach to software development. It portrays unidirectional communication between the cycle's activities. This model is considered to be linear, because it suggests a sequential systematic approach. Although originally Royce predicted a certain degree of iteration between consecutive activities (feedback loops), most corporations implement straightly linear waterfall methodologies.
The process begins with a requirements specification activity, in which the main functionality and services provided by the application are agreed upon with the relevant stakeholders. After that, the team designs the system, building a global architecture from the elicited requirements. The implementation activity follows and the solution is built, before being integrated and tested. There is also room for a maintenance phase, that implies bugfixing and overall improvement of the product. At each phase of the process, high priority is given to documentation.
The waterfall model is still a big favorite for development in the healthcare industry because of its plan driven nature (McCaffery et al., 2016) . Its stringency, attention to quality and priority to documentation stimulate the production of tangible evidences needed to satisfy regulations and audits.
On the other hand, this line of thought can become less appealing if the software solution has a more unpredictable nature concerning scope and requirements. The first working version of the software solution is only finalized in later stages of the development process and that can lead to very high costs in case something has to be changed.
The strictness of plan-driven approaches is advantageous in some points, mainly when certification is needed, as we have seen. However, with the introduction of the Medical Device Regulations, one can predict a change in the nature of the software aiming to become certified as medical devices, namely because more lightweight standalone applications will become relevant. Using a linear model in these cases can lead to frustration and become unappealing (Spence, 2005) .
Agile Approaches
In the eighties and beginning of the nineties, linear life cycle models based on quality assurance and strict planning were considered the standard approach to obtain quality. This vision came from experience developing critical systems (Ian Sommerville, 2010) . However, as this strategy began to be applied by teams in much smaller businesses, the overhead implied by the implementation of the development model itself became unbearable. Most of the resources available were needed just for quality assurance tasks, and not for development tasks.
The consequent discontent concerning waterfall approaches lead to the uprising of the Agile Manifesto (Agile Alliance, 2001 ). This line of thought gives high priority to ideas such as customer collaboration, reaction to change and communication between team individuals and disregards production of comprehensive documentation and following a rigid plan.
What makes agile so appealing is the priority given to accommodate change. In a traditional model, the cost of change rises non-linearly as the project progresses. This means that at later stages, when the stakeholders see the finished product, it's extremely costly to change anything. Agile proposes that change should be possible at any stage of the development process without major costs.
But the agile philosophy is more than that. It's a work paradigm where communication is encouraged between team members and fast delivery of working solutions is emphasized (Warden and Shore, 2008) .
SCRUM is a popular implementation of the agile philosophy introduced by Ken Schwaber and Jeff Sutherland (Schwaber, 1997) . It proposes incremental deliveries of working products through iterative cycles.
The SCRUM team includes an element called a Product Owner, who is the person in charge of maximizing the overall value of the solution, which is designed and built by the development team. He is responsible for prioritizing and ordering the development tasks, which are called user stories, in a product backlog. The development team should guaranty a functional delivery at the end of each increment.
The time frame between each delivery is called a sprint. The scrum master, who is part of the development team, is in charge of making sure the scrum process is followed and understood by all of those involved.
The plan-driven versus agile discussion is an interesting and relevant one. Discipline is the foundation for success at any diligence: athletes train, musicians practice to perfect their technique and engineers refine their processes. In the software world, craftsmanship is a term starting to gain popularity and describes the art of developing high quality, detail oriented software. On the other hand, agility is flexible and inventive, when discipline is rigid and predictable. Agility provides ability to exit comfort zones and react to the unexpected.
It is our strong opinion that any endeavor demands discipline and agility to succeed. Without agility, discipline translates to strong bureaucracy and stagnation; nonetheless, the opposite scenario is nothing but a startup that has yet to think about measurable profit (Boehm, 2004) .
Over the past two decades, the software development community has been defied by the agile movement to change its perspective radically. As aforementioned, the medical device landscape is also in the verge of drastic changes, with the introduction of standalone, lightweight applications into its ecosystem.
Although plan-driven methodologies have dominated the healthcare industry in the past, there is reason to argue in favor of the need to make the development processes more agile, in light of the medical device regulation's appearance. The ultimate goal should be to find a development model able to comply with regulations and standards, but also provides enough flexibility and ability to react to change.
A TAILORED AGILE APPROACH
Software process tailoring is the activity of tuning a process to meet the needs of a specific project or context (Xu and Ramesh, 2008) . We suggest a development life cycle model that allows compliance with the MDF and also IEC 62304:2006. This model is also an adaptation of SCRUM, allowing it to be agile and highly reactive to changes and scope. The ultimate goal is to provide the much needed structure for development of lightweight solutions certifiable as medical devices.
Life Cycle Description
An illustration of the suggested model is presented in figure 1 . The proposed activities are characterized as follows:
• Product Vision: Should normally happen during project proposal (in case there is a defined customer) and has no predetermined duration. During the product vision phase, the product owner, scrum master and user experience designers work together in order to create an overall vision of the product. A macro requirements analysis should be performed to gain better understanding of the solution, as well as general architecture concepts (system design) and user interface previews. The outcomes of this activity should be an extensive product backlog, a software architecture document and a software plan document (as demanded by the IEC 62304:2006 standard). By the end of the product vision, the team must have defined plans regarding traceability, risk management, problem resolution, testing and configuration management. Standards and conventions for development should also be defined at this stage.
• Sprint 0 (optional): Unlike the remaining sprints, Sprint 0 does not include SCRUM's ceremonies, as it is not an official Scrum sprint. It is fully devoted to reviewing the product vision's outcomes. Interface specifications and end-to-end proofs of concept should be performed in order to validate the proposed architecture (the complete development team should be available). Outputs of this phase include a full review of the product backlog, grooming of the backlog for Sprint 1, updated project plans and development infrastructure (Continuous Integration Server, Integrated Development Environment (IDE) configurations, test infrastructure). Another important outcome of Sprint 0 is the definition of "Done", which must be understood by the whole Project Team and equally applied across Sprints.
• Sprint: A Sprint is the development iteration, with duration between two and four weeks. This duration can vary according to the unique features of the medical device. Each Sprint aims at completely developing a scope, a product increment, meaning that it must include all required development, integration and testing activities to have a functional and demonstrable version of the software product at the end of the Sprint. When a Sprint kicks-off, elements outside the Development Team are not allowed to interfere in that Sprint. It is the Scrum Master's job to protect the development team from external interferences. All change requests are solely handled by the Scrum Master and only applicable in future Sprints. A Sprint is "Done" when all items are "Done", when all acceptance criteria are met and Sprint Goal is achieved. As outputs of each sprint, an updated specification of software requirements and an updated configuration items list must be produced in order to show evidence of these activities to regulatory authorities.
• Quality Assurance checkpoint: At the end of each sprint, an independent quality assurance team performs an internal audit, reviewing deliverables and all evidences for certification by the medical device regulation and the IEC 62304:2006 standard. The members of this team must not be part of development team. A non-conformance report should be built and non-conformities introduced in the product backlog by the product owner. This approach was already implemented successfully in the R-Scrum model (Fitzgerald et al., 2013) .
Scrum Ceremonies
• Sprint Planning: Each Sprint starts with a Sprint Planning Meeting. This ceremony has the purpose of defining the scope of the Sprint and detailing the tasks to accomplish that scope. During this meeting, the team must decide on the scope to be done (What to do?), and how they will include that functionality (How to do?). The product owner has the responsibility of presenting an updated and prioritized product backlog, so that the team can accurately estimate each user story to be included in the next sprint (Sprint Backlog). Additionally, during the sprint meeting, the product owner and scrum master should identify the risks concerning the items selected for the sprint. At each planning, these risk should be reevaluated and iterated. Risk management is a very important part of medical device development and evidences of this are needed for certification. Ultimately, the product owner should be responsible for managing the risk management items.
• • Sprint Retrospective: The purpose of this meeting is for the Team and the Scrum Master to look back at the Sprint to make the process more effectivedelivering the user stories -and more enjoyable -more satisfactory for the Team members. This meeting takes place after the Sprint Review Meeting and before the next Sprint Planning Meeting. The findings of this meeting must be in the form of actionable improvement measures.
• Daily Scrum: Daily management of Sprint execution is performed by conducting daily short meetings (15 minutes maximum).
Process Validation
The proposed model will be validated by a team of students of the Faculty of Engineering of the Univer-sity of Porto. The students will be developing a standalone software system, provisionally classified as a Class C medical device. The main goal of this study will be to implement the suggested tailored Scrum process and evaluate if it is beneficial for the development team in two key aspects:
1. The process allows the final product to be successfully classified as a medical device, according to the Medical Device Regulations and IEC 62304:2006.
2. The process does not put Scrum and Agile's main advantages at jeopardy by introducing additional overhead.
These conclusions can be obtained through existing metrics and studies. For example, Abrahamsson et al. presented a study where software life cycles are analyzed and evaluated (Abrahamsson et al., 2002) . Alson, Boehm (Boehm, 2004 ) presented a comprehensive comparison between different models in order to study the balance between agility and discipline. The author collected metrics like budget performance, schedule achievement, team satisfaction and defect rate.
CONCLUSIONS
Balancing agility and discipline is everything but a simple task when dealing with software development life cycles, particularly in the critical system domain, such as is the case with medical devices.
However, there are no tangible evidences preventing agile methodologies from benefiting development teams in the task of building valuable medical devices. In 2017, with the introduction of the new Medical Device Regulations, one can expect the development of standalone software systems legally certified as medical devices which are lightweight and operating in fast changing environments. This demands a renewal of the way the software community is used to building these systems.
It is a fact "out of the box" that Agile methods such as Scrum have some shortfalls regarding highly regulated ecosystems (McHugh et al., 2012) . However, these barriers are either a result of misunderstandings of the agile philosophy or can be overcome through tailoring. For example, it's generally assumed that agile disregards documentation, but these documents can be written if they are highly prioritized by the product owner (agile aims to deliver value most of all). Traceability can be achieved through the use of the appropriate tools and risk management evidences can be created, as we have shown, in each sprint planning meeting.
The software community has reason to embrace these changes in the medical device landscape with excitement, because they represent an opportunity to create software that can make positive changes in people's lives on a daily basis. Given these new circumstances, a mobile application can very well be certified as a medical device, and this means it can possibly be prescribed to a patient by a medical doctor. On the other hand, development processes must be rethought to face these challenges.
